Nettle Root

Best-in-class: Stinging Nettle Root

A root extract used for prostate health and to modestly free up testosterone by binding SHBG — often stacked for hormone and hair support.

How Nettle Root actually works

Root rather than leaf, which is a different product entirely. Lignans bind SHBG in vitro, theoretically displacing testosterone and raising the free fraction, and there is weak 5-alpha-reductase inhibition and aromatase inhibition alongside. The in vitro binding does not clearly translate to changed serum hormones in humans.

Where to get Nettle Root

The evidence for Nettle Root

Graded by what exists behind each claim.

✅ Clinically validated

• RCTs support improved BPH/urinary symptoms; binds SHBG to raise free testosterone modestly.
• May inhibit some DHT conversion (hair/prostate relevance).

📊 Correlative data

• Long European traditional use for urinary complaints in older men, which maps onto the modern BPH application. Widely used in Germany with real population exposure and a good tolerability record.

🧪 Theoretical / extrapolated benefits

• Free-testosterone and hair benefits are plausible but modest.

How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →

What Nettle Root actually does

Root and leaf are two different medicines and the first thing to fix is which one this is. Urtica dioica leaf carries the stinging hairs, the histamine and the diuretic tradition. The root — urticae radix, the subject of its own review Chrubasik 2007 — carries lignans, phytosterols and polysaccharides, and everything on this page is about the root. A product labeled ‘nettle’ without the word root is not this product.

The molecular claim is a protein-binding one, and that is unusual enough to be worth stating precisely. Sex hormone binding globulin is a plasma glycoprotein that binds testosterone and estradiol with high affinity and sets the free fraction. Nettle root's proposed mechanism is not enzyme inhibition and not receptor agonism. It is direct binding to SHBG itself — a ligand occupying a transport protein.

And the binding was measured, molecule by molecule. Lignans isolated from Urtica dioica roots, and the metabolites they become, were tested against human SHBG. All of them bound except (−)-pinoresinol, and the affinity of (−)-3,4-divanillyltetrahydrofuran was outstandingly high among them Schottner 1997. One molecule, named, standing well clear of its structural relatives — which is what a real structure–activity relationship looks like rather than an extract doing something diffuse.

The methodological paper underneath it is the one that shows how sensitive this is to chemistry. A test method for plant constituents interfering with human SHBG was developed and applied to Urtica dioica root extracts, and methylating the active mixture increased its activity about tenfold Gansser 1995. A single methyl group, ten times the effect. That is a binding site with real steric requirements, and it is also a warning: the fraction that survives your extraction process is the fraction you are testing.

The second, quieter mechanism is aromatase, and it is weak on purpose. The same group isolated aromatase inhibitors from Urtica dioica roots — secoisolariciresinol, oleanolic acid, ursolic acid and 14-octacosanol — and characterized their activity as weak to moderate, with no IC₅₀ values reported Gansser 1995. Aromatase converts testosterone to estradiol, so a weak inhibitor in the root is the structural basis of the men's-hormone marketing. ‘Weak to moderate’ with no number attached is exactly as far as that evidence goes.

What is not here, and its absence is the honest headline. There is no 5-alpha-reductase inhibition constant for nettle root in this file. The rodent work compared nettle extracts against finasteride 1 mg/kg as a positive control in a testosterone-induced model Nahata 2012, which is a comparison, not a demonstration that nettle inhibits the same enzyme. The card says nettle may inhibit some DHT conversion. The measured mechanism in the primary literature is SHBG binding Schottner 1997 Gansser 1995 and weak aromatase inhibition Gansser 1995, and those are different enzymes doing different jobs.

Cell, rodent, human — and where it stops

Test tube: human protein, named molecules, real affinity differences. Human SHBG, isolated root lignans and their metabolites, one standout ligand Schottner 1997, and a tenfold shift from methylation Gansser 1995. No species gap at this step.

Rodent: a hyperplasia model with doses. Rats received testosterone 3 mg/kg for 28 days to induce prostatic hyperplasia, with Urtica dioica extracts given orally at 10, 20 and 50 mg/kg, isolated beta-sitosterol at 10 and 20 mg/kg, and finasteride 1 mg/kg as the positive comparator Nahata 2012. Note what the design implies: the effect was attributed partly to beta-sitosterol, tested separately, which means part of nettle root's rodent activity is a phytosterol effect rather than a lignan effect.

Human: one large trial, and its numbers are better than the category deserves. Six hundred and twenty men were randomized to Urtica dioica or placebo for six months. At six months 232 of 287 (81%) on nettle reported improved lower urinary tract symptoms against 43 of 271 (16%) on placebo (P < 0.001). The International Prostate Symptom Score fell from 19.8 to 11.8 on nettle against 19.2 to 17.7 on placebo (P = 0.002) Safarinejad 2005. An eight-point IPSS fall against a one-and-a-half-point placebo fall is a large, controlled, six-month effect, and a second randomized double-blind study in 100 patients sits beside it Ghorbanibirgani 2013.

Now the obstacle, and it is not the one you would expect — the urinary evidence is the strong part. Not one of these studies measured a hormone. The trial that moved IPSS by eight points reported urinary endpoints Safarinejad 2005. The mechanism papers measured protein binding in a tube Schottner 1997 Gansser 1995. Nobody has drawn SHBG, total testosterone or free testosterone in a human taking nettle root. The card's headline claim — binds SHBG to raise free testosterone modestly — rests on an in-vitro binding assay with no human measurement anywhere behind it.

And there is a direction problem inside the claim itself. A ligand that occupies SHBG could displace bound testosterone and raise the free fraction; it could equally bind at a site that changes nothing, or be present at concentrations orders of magnitude below the circulating SHBG pool. A binding affinity in a purified system Schottner 1997 does not tell you which, because it says nothing about how much of the ligand reaches plasma. That measurement — plasma concentration of 3,4-divanillyltetrahydrofuran after an oral dose — has not been published.

The third obstacle is that the sister page on this site already showed what happens when somebody checks. When pygeum products were assayed against the bark they are made from, the compound carrying that plant's most-quoted receptor mechanism could not be detected in any sample Thompson 2019. Nobody has run that experiment on nettle root. The lignan content of commercial nettle root products is unpublished, unregulated and absent from every label.

Nettle Root — which form, and does it matter

Root, not leaf, and the label must say so. The review that covers this material is explicitly Part II, urticae radix, separate from the leaf Chrubasik 2007; the leaf has a diuretic and anti-inflammatory tradition and a different chemistry. Any product that says only ‘nettle’, or that blends aerial parts with root, is not the material any trial on this page used.

Which solvent, because the actives split between two fractions. The lignans that bind SHBG are moderately polar Schottner 1997; the beta-sitosterol that carried part of the rodent effect is a lipophilic sterol Nahata 2012; the polysaccharides are aqueous. Traditional European preparations are 20% methanolic or aqueous-ethanolic root extracts, and those are the kind of extract the clinical literature was built on Chrubasik 2007. A dried root powder at the same milligram number is a different product: it contains everything the plant contained at the plant's own concentration, which is much lower than an extract's.

The methylation finding is the reason processing matters more here than usual. Methylating the active mixture raised SHBG-binding activity roughly tenfold Gansser 1995. That is a laboratory derivatization rather than a manufacturing step, but it establishes that small chemical changes to these lignans produce order-of-magnitude changes in the measured activity — so drying temperature, solvent and storage are not neutral, and no manufacturer publishes any of them.

What a nettle root label should carry and none does. A lignan content, ideally naming 3,4-divanillyltetrahydrofuran, and a beta-sitosterol percentage. Those are the two constituent classes with measured activity in this file Schottner 1997 Nahata 2012. What labels state instead is milligrams of extract and an extract ratio, neither of which is a dose of anything.

The dose that has evidence, and the one on the card. The card says 300–600 mg of root extract daily, which is the conventional European range and matches the traditional preparations Chrubasik 2007. The six-month trial that produced the eight-point IPSS fall used a defined extract Safarinejad 2005. Buy on the word root, on a stated extract type, and on a manufacturer who names their extract — and understand that even then you are buying the closest available approximation to the trial material rather than the trial material.

What would have to be true, and how you would know it was not

1. shbg and free testosterone — the card's own claim, tested properly for the first time. Draw SHBG, total testosterone and calculated free testosterone before starting and at twelve weeks. If nettle root does what the shelf says, free testosterone rises while total testosterone does not, because displacing steroid from a binding protein redistributes it rather than making more. That dissociation — free up, total flat — is the signature to look for, and it is not what a testosterone booster that worked on the gonad would produce. Nobody has ever published this panel on nettle root.

2. The prediction that cuts against the product, and it is the same panel read the other way. Predict that SHBG, total testosterone and free testosterone are all unchanged at twelve weeks. The binding evidence is an in-vitro affinity for an isolated protein Schottner 1997 Gansser 1995 with no human plasma concentration behind it, and every human trial that measured anything measured urine flow rather than hormones Safarinejad 2005. If the panel is flat, nettle root is a urinary-symptom product with a hormone story bolted on, and the men buying it for hair and free testosterone bought the wrong thing.

3. estradiol, for the aromatase claim. Weak-to-moderate aromatase inhibitors were isolated from the root Gansser 1995. So predict estradiol on a sensitive mass-spectrometry assay is unchanged at a retail dose, and treat a fall as the finding that would justify the marketing. One line on the same requisition as the testosterone panel.

4. The symptom score, with a number that belongs to nettle rather than to the category. From a baseline near 20, predict an IPSS fall toward the high single digits by six months, against roughly two points of placebo drift — that is 19.8 to 11.8 versus 19.2 to 17.7 in the trial Safarinejad 2005. Six months, not twelve weeks: that trial's separation is a six-month result and stopping at eight weeks is stopping before the evidence says to look.

5. psa, drawn once before the first capsule. Not because nettle root has a demonstrated PSA effect — no trial in this file reports one, so it is neither shown nor excluded — but because the aromatase and SHBG mechanisms both act on the androgen environment the prostate sits in Gansser 1995 Schottner 1997, and a PSA taken later with no baseline cannot be interpreted. The men most likely to take this are exactly the men whose next PSA will matter.

What nobody has tested yet

Nobody has drawn a hormone in a person taking nettle root. The mechanism is thirty years old Gansser 1995 Schottner 1997, the largest trial randomized 620 men for six months Safarinejad 2005, and SHBG, total testosterone, free testosterone and estradiol have never been reported together in a nettle root trial. Adding four assays to an existing BPH protocol is a few dollars a participant. Thirty years.

Nobody has measured whether the lignan reaches plasma. (−)-3,4-divanillyltetrahydrofuran has an outstanding affinity for SHBG in a tube Schottner 1997. Whether an oral dose of root extract puts any of it into the circulation at a concentration approaching the circulating SHBG pool is the question that decides whether the entire hormone story is possible, and no pharmacokinetic study exists.

Nobody has assayed the products against the root. That experiment has been done for a directly comparable prostate botanical, and the most-quoted active was undetectable in every commercial sample Thompson 2019. For nettle root the equivalent survey — lignan and beta-sitosterol content of the top-selling products against authenticated root — has not been published, which means nobody can say whether retail nettle root resembles trial nettle root.

And nobody has separated nettle from the things it is sold with. It is routinely combined with saw palmetto, pygeum and boron, and the combination trials cannot attribute an effect to any one component. A three-arm trial — nettle alone, saw palmetto alone, both — would tell men whether they are paying for one active ingredient or three, and it has never been run at the dose people buy.

Nettle Root — its own safety story, not its category's

Nettle root is genuinely one of the better-tolerated things in this category, and the evidence for that is a number rather than an impression. Six hundred and twenty men took it for six months in a randomized trial and the report is of symptom improvement without a safety signal Safarinejad 2005; the review of the root's efficacy and tolerability reaches the same conclusion Chrubasik 2007. Mild gastrointestinal upset is the complaint that appears, and it appears on placebo too.

The specific risk on this page is not toxicity, it is the hormone claim being taken seriously without measurement. If the SHBG mechanism is real Schottner 1997, then nettle root changes the free fraction of circulating testosterone and estradiol — which is a hormonal intervention in a man who thinks he bought a herb for his bladder. If it is not real, he is treating a prostate with an inert hormone claim. Nobody can tell him which, because the panel has never been drawn Safarinejad 2005. The reasonable response is to draw it rather than to argue about it.

The interaction that follows from the mechanism rather than from a list. A weak aromatase inhibitor Gansser 1995 stacked on top of a prescribed aromatase inhibitor, or taken alongside testosterone replacement, is an unmeasured addition to a carefully titrated hormonal regimen. Estradiol is the marker that would show it and it costs one line. This is a mechanism-level caution, not a documented interaction, and it should be weighed as one.

The real harm here is the same one that sits under every urinary-symptom product, and it has a clock on it. The trial that justifies buying this ran six months Safarinejad 2005. Lower urinary tract symptoms are also the presenting complaint of bladder and prostate cancer, infection, stones and neurogenic bladder. Six months of self-treatment is six months a cause is not looked for. Visible blood in the urine, inability to pass urine, fever with flank pain, or a rapid worsening are same-week medical problems, and no root extract changes that.

Two smaller ones, both worth stating precisely. The card notes nettle may lower blood pressure and blood sugar slightly; that is a reason to watch for additive effects on medication rather than a documented interaction, and neither has been quantified in the trials here. And the root's rodent activity was attributed partly to beta-sitosterol Nahata 2012, which makes a sterol-enriched nettle product a phytosterol load — relevant to anyone with sitosterolemia, and a reason to know which fraction you bought.

Sources read for this page

• Schottner M, et al. Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG). Planta Medica 1997;63(6):529-532 · PMID 9434605
• Gansser D, Spiteller G. Plant constituents interfering with human sex hormone-binding globulin. Evaluation of a test method and its application to Urtica dioica root extracts. Zeitschrift fur Naturforschung C 1995;50(1-2):98-104 · PMID 7702715
• Gansser D, Spiteller G. Aromatase inhibitors from Urtica dioica roots. Planta Medica 1995;61(2):138-140 · PMID 17238068
• Safarinejad MR. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study. Journal of Herbal Pharmacotherapy 2005;5(4):1-11 · PMID 16635963
• Ghorbanibirgani A, et al. The efficacy of stinging nettle (urtica dioica) in patients with benign prostatic hyperplasia: a randomized double-blind study in 100 patients. Iranian Red Crescent Medical Journal 2013;15(1):9-10 · PMID 23487561
• Nahata A, Dixit VK. Ameliorative effects of stinging nettle (Urtica dioica) on testosterone-induced prostatic hyperplasia in rats. Andrologia 2012;44(Suppl 1):396-409 · PMID 21806658
• Chrubasik JE, et al. A comprehensive review on the stinging nettle effect and efficacy profiles. Part II: urticae radix. Phytomedicine 2007;14(7-8):568-579 · PMID 17509841
• Thompson RQ, et al. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health. Journal of Pharmaceutical and Biomedical Analysis 2019 · PMID 30316061

How you would know if it worked

Nettle Root — safety & side effects

Bloodwork to run alongside Nettle Root

Baseline first, then again at 8–12 weeks.

The “Low T? Rule Out the Reversible Causes First” panel covers these in one order — 11 markers, $211.50 with the discount applied.

Check results you already have → · All 103 markers A–Z

Nettle Root — frequently asked questions

Nettle Root inside a finished plan

One arm of 1 Protocol Blueprint, free to read in full.

What Nettle Root is used for

Nettle Root appears under 1 goal in the goal router.

Related Hormonal & Wellness supplements

← Browse the full Supplement Vault

↑ Back to on this page